ONCODESIGN BIOTECHNOLOGY, leader in oncological therapy assessments

Philippe GENNE, President and CEO, Oncodesign Biotechnology, Dijon “Oncodesign Biotechnology is market leader in the assessment of oncological therapies With over 400 pharmaceutical clients throughout the world, the company makes its contribution to the Pharm’image excellence centre. Unique in France, it is made up of businesses, University hospitals, George –François Leclerc cancer centres and university laboratories. This centre is dedicated to offering Pharma laboratories continuity of skills and research platforms in pharmaco- imaging applied to therapies and to anticancer diagnoses”.

2010/06/22